Joseph Jimenez
Chairman at CENTURY THERAPEUTICS, INC.
Net worth: 8 M $ as of 2024-04-29
Profile
Mr. Joseph Jimenez is an Independent Director at Graphite Bio, a Chairman at Century Therapeutics LLC, a Director & Managing Director at Aditum Bio Fund 1 LP, an Independent Director at Procter & Gamble Co., an Independent Director at General Motors Co. and a President at European Federation of Pharmaceutical Industries & Assns. He is on the Board of Directors at Graphite Bio, Aditum Bio Fund 1 LP, Procter & Gamble Co. and General Motors Co. Mr. Jimenez was previously employed as a Chairman-Elect by Pharmaceutical Research & Manufacturers of America, an Independent Director by Colgate-Palmolive Co., a Chairman by Speedel Holding AG, a General Director by Novartis Pharma Schweiz AG, a Chief Executive Officer by Novartis AG, a Chief Executive Officer by Novartis Consumer Health, Inc., a Non-Executive Director by AstraZeneca Plc, an Executive Vice President by H.J. Heinz Co., a President, Chief Executive Officer & Executive VP by Heinz Europe Ltd., a President & Chief Executive Officer by Heinz North America Consumer Products, a President- & Senior Vice President by ConAgra Foods, Inc., a Chief Executive Officer by Novartis Pharmaceuticals Corp., and a Chairman by Speedel Pharma AG. He also served on the board at uBiome, Inc., Blue Nile, Inc., Pinnacle Foods Finance LLC and Pinnacle Foods Group LLC. He received his undergraduate degree from Stanford University and an MBA from the University of California, Berkeley.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
PROCTER & GAMBLE COMPANY
0.00% | 2024-03-11 | 30,384 ( 0.00% ) | 5 M $ | 2024-04-29 |
2024-04-18 | 494,345 ( 0.76% ) | 2 M $ | 2024-04-29 | |
GENERAL MOTORS COMPANY
0.00% | 2024-03-30 | 32,330 ( 0.00% ) | 1 M $ | 2024-04-29 |
0.09% | 2024-01-31 | 23,134 ( 0.09% ) | 357 420 $ | 2024-04-29 |
Joseph Jimenez active positions
Companies | Position | Start |
---|---|---|
GENERAL MOTORS COMPANY | Director/Board Member | 2015-06-08 |
PROCTER & GAMBLE COMPANY | Director/Board Member | 2018-02-28 |
CENTURY THERAPEUTICS, INC. | Chairman | 2021-05-04 |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | President | 2014-12-17 |
Teres Bio, Inc.
Teres Bio, Inc. Pharmaceuticals: MajorHealth Technology Teres Bio, Inc. operates as a clinical stage life sciences company. It translates discoveries in inflammatory pathways into novel, topical therapies for atopic dermatitis and plaque psoriasis skin diseases. The company is headquartered in Oakland, CA. | Director/Board Member | - |
Anteris Bio, Inc.
Anteris Bio, Inc. Pharmaceuticals: MajorHealth Technology Anteris Bio, Inc. develops therapies for the treatment of renal disease. The company is based in Oakland, CA. The CEO of the company is Ilan Zipkin. | Director/Board Member | - |
Via Nova Therapeutics, Inc.
Via Nova Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Via Nova Therapeutics, Inc. is a company that aims to discover and develop safe and effective therapies for viral diseases with inadequate treatments. The company is based in Oakland, CA. Via Nova's pipeline includes four programs targeting influenza, human rhinovirus, polyomavirus, and adenovirus. The company is committed to advancing this initial pipeline with additional discovery efforts to follow. Via Nova believes that the recent expansion of point-of-care testing and telemedicine driven by the COVID-19 pandemic will transform the diagnostic landscape, allowing early recognition of all the important respiratory viruses. The company was founded in August 2021 and has in-licensed antiviral programs from RTIs. The CEO of the company is Donald Emil Ganem. | Director/Board Member | - |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million. | Director/Board Member | - |
Aditum Bio Management Co. LLC
Aditum Bio Management Co. LLC Investment ManagersFinance Aditum Bio Management Co. LLC is a biotech venture capital company based in Oakland, CA. Aditum Bio is committed to improving public health by accelerating research and development in disease areas with both large and more targeted patient populations. The private company focuses on basic mechanisms of disease, in-license promising drug candidates, and spin-out individual companies dedicated to bringing each candidate through phase II clinical trials. In partnership with Trialspark, Aditum Bio uses data, software, and technology to help bring innovative medicines through the clinical trial phase more quickly and with lower costs than traditional pharmaceutical companies. The company was founded by Paul Sekhri, Joseph Jimenez, and Mark Fishman. | Founder | - |
░░░░░░ ░░░ ░░░░ ░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Former positions of Joseph Jimenez
Companies | Position | End |
---|---|---|
░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Joseph Jimenez
Stanford University | Undergraduate Degree |
University of California, Berkeley | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 7 |
---|---|
ASTRAZENECA PLC | Health Technology |
NOVARTIS AG | Health Technology |
COLGATE-PALMOLIVE COMPANY | Consumer Non-Durables |
GENERAL MOTORS COMPANY | Consumer Durables |
CONAGRA BRANDS, INC. | Consumer Non-Durables |
PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
CENTURY THERAPEUTICS, INC. | Health Technology |
Private companies | 23 |
---|---|
H.J. Heinz Co.
H.J. Heinz Co. Food: Major DiversifiedConsumer Non-Durables H.J. Heinz Co. used to produced processed food products. Its products included ketchup, condiments and sauces, frozen food, soups, beans and pasta meals, infant nutrition and other food products. H.J. Heinz was founded by Henry John Heinz in 1869 and was headquartered in Pittsburgh, PA. | Consumer Non-Durables |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Heinz North America Consumer Products
Heinz North America Consumer Products Food: Specialty/CandyConsumer Non-Durables Heinz North America Consumer Products manufactures snack foods. Its products include mustard and barbecue and pasta sauces that are sold under the Heinz 57, Jack Daniels, Classico pasta sauces, and Lea & Perrins Worcestershire brands. The company is located in Pittsburgh, PA. | Consumer Non-Durables |
Pinnacle Foods Group LLC
Pinnacle Foods Group LLC Food: Specialty/CandyConsumer Non-Durables Pinnacle Foods Group LLC operates as a producer, marketer, and distributor of shelf stable and frozen food products. Its products are sold through supermarkets, grocery wholesalers and distributors, mass merchandisers, convenience stores, warehouse clubs and military channels. The company was founded on June 19, 1998 and is headquartered in Parsippany, NJ. | Consumer Non-Durables |
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Commercial Services |
Novartis Consumer Health, Inc.
Novartis Consumer Health, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Novartis Consumer Health, Inc. manufactures and supplies pharmaceutical products. The company is based in Lincoln, NE. | Health Technology |
Speedel Holding AG
Speedel Holding AG Pharmaceuticals: MajorHealth Technology Speedel Holding operates as a holding company with interests in pharmaceutical manufacturing. The company was founded on July 19, 2000 and is headquartered in Basel, Switzerland. | Health Technology |
Speedel Pharma AG
Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Health Technology |
Pinnacle Foods Finance LLC
Pinnacle Foods Finance LLC Food: Major DiversifiedConsumer Non-Durables Pinnacle Foods Finance LLC produces and markets food products. The company was founded on March 5, 2007 and is headquartered in Parsippany, NJ. | Consumer Non-Durables |
Heinz Europe Ltd. | |
Blue Nile, Inc.
Blue Nile, Inc. Specialty StoresRetail Trade Blue Nile, Inc. engages in the retail of diamonds and fine jewellery. Its merchandise consists of engagement and non-engagement products. The engagement product category includes gold or platinum engagement rings with a diamond centre stone and loose diamonds. The non-engagement product category includes rings, wedding bands, earrings, necklaces, pendants, bracelets, gifts, and accessories containing precious metals, diamonds, and gemstones or pearls. The company was founded by Ben Elowitz, Mark C. Vadon and Anne Raimondi in 1999 and is headquartered in Bellevue, WA. | Retail Trade |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Commercial Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
uBiome, Inc.
uBiome, Inc. Electronic Equipment/InstrumentsElectronic Technology uBiome, Inc. operates as a biotechnology company. It provides information and tools to explore the populations of bacteria that live on and inside human body. The firm sends customers a kit to collect a tiny stool, mouth, nose, genitals and skin sample and the samples, coupled with a detailed questionnaire, let uBiome's lab compare results with a stockpile of other information from a user database. The company was founded by Zachary Apte and Jessica Richman in November 2012 and is headquartered in San Francisco, CA. | Electronic Technology |
Aditum Bio Fund 1 LP
Aditum Bio Fund 1 LP Investment ManagersFinance Aditum Bio Fund 1 LP specializes in acquiring and developing pharmaceutical assets. The company is headquartered in San Mateo, CA. | Finance |
Graphite Bio, Inc.
Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
Century Therapeutics, Inc. /Old/
Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Century Therapeutics, Inc. operates as a biotechnology company. It develops transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with significant unmet medical need. The company has created a allogeneic cell therapy platform that includes induced pluripotent stem cells, or iPSCs, differentiation know-how to generate immune effector cells from iPSCs, or iPSC-derived cells, clustered regularly interspaced short palindromic repeats, or CRISPR, mediated precision gene editing that allows it to incorporate multiple transgenes and remove target genes intended to optimize cell product performance, sophisticated protein engineering capabilities to develop proprietary next generation chimeric antigen receptors, or CARs, its proprietary Allo-EvasionTM technology intended to prevent rejection of its cell products by the host immune system, and cutting edge manufacturing capabilities intended to minimize product development and supply risk. Century Therapeutics was founded on March 5th, 2018 and is headquartered by Philadelphia, PA. | Health Technology |
Aditum Bio Management Co. LLC
Aditum Bio Management Co. LLC Investment ManagersFinance Aditum Bio Management Co. LLC is a biotech venture capital company based in Oakland, CA. Aditum Bio is committed to improving public health by accelerating research and development in disease areas with both large and more targeted patient populations. The private company focuses on basic mechanisms of disease, in-license promising drug candidates, and spin-out individual companies dedicated to bringing each candidate through phase II clinical trials. In partnership with Trialspark, Aditum Bio uses data, software, and technology to help bring innovative medicines through the clinical trial phase more quickly and with lower costs than traditional pharmaceutical companies. The company was founded by Paul Sekhri, Joseph Jimenez, and Mark Fishman. | Finance |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million. | Health Technology |
Via Nova Therapeutics, Inc.
Via Nova Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Via Nova Therapeutics, Inc. is a company that aims to discover and develop safe and effective therapies for viral diseases with inadequate treatments. The company is based in Oakland, CA. Via Nova's pipeline includes four programs targeting influenza, human rhinovirus, polyomavirus, and adenovirus. The company is committed to advancing this initial pipeline with additional discovery efforts to follow. Via Nova believes that the recent expansion of point-of-care testing and telemedicine driven by the COVID-19 pandemic will transform the diagnostic landscape, allowing early recognition of all the important respiratory viruses. The company was founded in August 2021 and has in-licensed antiviral programs from RTIs. The CEO of the company is Donald Emil Ganem. | Health Technology |
Anteris Bio, Inc.
Anteris Bio, Inc. Pharmaceuticals: MajorHealth Technology Anteris Bio, Inc. develops therapies for the treatment of renal disease. The company is based in Oakland, CA. The CEO of the company is Ilan Zipkin. | Health Technology |
Teres Bio, Inc.
Teres Bio, Inc. Pharmaceuticals: MajorHealth Technology Teres Bio, Inc. operates as a clinical stage life sciences company. It translates discoveries in inflammatory pathways into novel, topical therapies for atopic dermatitis and plaque psoriasis skin diseases. The company is headquartered in Oakland, CA. | Health Technology |
The Blackstone Group
The Blackstone Group Investment ManagersFinance Part of Blackstone, Inc., The Blackstone Group enables leading energy companies to build enterprises at scale that can deliver clean, reliable and affordable energy to help meet needs. The company is based in Beijing, China. The Chinese company invests in companies shaping the future, helping emerging leaders become champions through the power of the Blackstone platform. | Finance |
- Stock Market
- Insiders
- Joseph Jimenez